Updated and Latest Questions and Correct Answers with
Rationale
1. Which pharmacokinetic process is primarily affected by a patient’s low serum albumin
levels?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Ans: A
Rationale: Distribution is the phase where drugs are transported through the blood to various tissues.
Many drugs bind to serum albumin to stay in the circulation before reaching their targets. If albumin
levels are low, there is less binding capacity available for these drugs. This results in an increase in the
free or active fraction of the drug. Such changes can lead to higher risks of toxicity in the patient.
Clinicians must carefully monitor drug levels when protein levels are compromised.
,2. How many half-lives does it typically take for a drug to reach a steady-state concentration
in the body?
A. 1 to 2
B. 2 to 3
C. 8 to 10
D. 4 to 5
Ans: D
Rationale: Steady state occurs when the rate of drug administration equals the rate of drug elimination.
In clinical pharmacology, this equilibrium is generally achieved after four to five half-lives. At this point,
the amount of drug in the body remains relatively constant. Knowing this timeline is essential for
determining when to measure therapeutic drug levels. If a dose is changed, it will take another four to
five half-lives to reach a new steady state. Understanding this concept helps providers manage patient
expectations regarding drug efficacy.
3. Which of the following drug schedules includes substances with a high potential for abuse
but have a currently accepted medical use?
A. Schedule I
B. Schedule IV
C. Schedule II
D. Schedule V
Ans: C
,Rationale: The Controlled Substances Act categorizes drugs into five distinct schedules based on risk.
Schedule II drugs exhibit a high potential for abuse and may lead to severe physical dependence. Despite
these risks, they have recognized and accepted medical applications in the United States. Examples
include medications like morphine, oxycodone, and various methylphenidate products. Prescribing these
substances requires strict adherence to federal and state regulations. Providers must ensure proper
documentation and patient monitoring when utilizing Schedule II medications.
4. What is the primary physiological change in geriatric patients that affects the renal
excretion of drugs?
A. Increased bladder capacity
B. Decreased urine acidity
C. Increased renal blood flow
D. Decreased glomerular filtration rate
Ans: D
Rationale: Aging is associated with a natural decline in kidney function and efficiency. Specifically, the
glomerular filtration rate typically decreases as individuals grow older. This reduction means that drugs
primarily cleared by the kidneys will stay in the body longer. Prolonged drug presence increases the risk
of adverse effects and toxicity in elderly patients. It is standard practice to calculate creatinine clearance
to adjust dosages accurately. Recognizing this physiological shift is a cornerstone of safe geriatric
pharmacological management.
, 5. A drug that binds to a receptor and produces a maximal biological response is referred to
as a(n):
A. Antagonist
B. Partial agonist
C. Inverse agonist
D. Full agonist
Ans: D
Rationale: Pharmacodynamics describes how drugs interact with receptors to produce specific
biological effects. A full agonist is a molecule that binds to a receptor and activates it completely. This
binding triggers the maximum possible response the receptor system can provide. In contrast, partial
agonists only produce a sub-maximal effect regardless of concentration. Understanding these
interactions allows providers to predict the intensity of a drug’s action. Selecting the correct agonist type
is vital for achieving desired therapeutic outcomes.
6. The ‘First-Pass Effect’ primarily occurs following which route of administration?
A. Oral
B. Sublingual
C. Intravenous
D. Intramuscular
Ans: A